A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

Ieda Hospital, Toyota

Hirosaki University Hospital, Hirosaki

Tsujinaka Hospital, Kashiwa

Toho University Sakura Medical Center, Sakura

Fukuoka University Chikushi Hospital, Chikushino-shi

Sapporo Kosei General Hospital, Sapporo

Hyogo College of Medicine Hospital, Nishinomiya

Ofuna Chuo Hospital, Kamakura

Kitasato University Hospital, Sagamihara

Yokohama City University Medical Center, Yokohama

Tohoku University Hospital, Sendai

Jichi Medical University Hospital, Shimotsuke

Institute of Science Tokyo Hospital, Bunkyo-ku

Juntendo University Hospital, Bunkyo-ku

Kitasato University Kitasato Institute Hospital, Minato-ku

Kyorin University Hospital, Mitaka

Keio University Hospital, Shinjuku-ku

Tokyo Yamate Medical Center, Shinjuku-ku

Infusion Clinic., Osaka

Osaka Metropolitan University Hospital, Osaka